Cargando…
Present and future perspectives on immunotherapy for advanced renal cell carcinoma: Going to the core or beating around the bush?
Metastatic lesions of renal cell carcinoma (RCC) occasionally regress spontaneously after surgical removal of the primary tumor. Although this is an exceptionally rare occurrence, RCC has thus been postulated to be immunogenic. Immunotherapies, including cytokine therapy, peptide-based vaccines, and...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Codon Publications
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5345540/ https://www.ncbi.nlm.nih.gov/pubmed/28326259 http://dx.doi.org/10.15586/jkcvhl.2015.24 |